Penumbra (PEN) Gross Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.00 |
| Dec 31, 2025 | 23.00 |
| Sep 30, 2025 | 179.00 |
| Jun 30, 2025 | -61.00 |
| Mar 31, 2025 | -18.00 |
| Dec 31, 2024 | 25.00 |
| Sep 30, 2024 | 1,215.00 |
| Jun 30, 2024 | -1,062.00 |
| Mar 31, 2024 | -68.00 |
| Dec 31, 2023 | 9.00 |
| Sep 30, 2023 | 178.00 |
| Jun 30, 2023 | 123.00 |
| Mar 31, 2023 | 1.00 |
| Dec 31, 2022 | -76.00 |
| Sep 30, 2022 | -100.00 |
| Jun 30, 2022 | 184.00 |
| Mar 31, 2022 | 100.00 |
| Dec 31, 2021 | -158.00 |
| Sep 30, 2021 | -134.00 |
| Jun 30, 2021 | -139.00 |
| Mar 31, 2021 | 929.00 |
| Dec 31, 2020 | -367.00 |
| Sep 30, 2020 | -159.00 |
| Jun 30, 2020 | -231.00 |
| Mar 31, 2020 | -347.00 |
| Dec 31, 2019 | -126.00 |
| Sep 30, 2019 | -118.00 |
| Jun 30, 2019 | 466.00 |
| Mar 31, 2019 | 17.00 |
| Dec 31, 2018 | -193.00 |
| Sep 30, 2018 | 119.00 |
| Jun 30, 2018 | 109.00 |
| Mar 31, 2018 | -154.00 |
| Dec 31, 2017 | 107.00 |
| Sep 30, 2017 | 208.00 |
| Jun 30, 2017 | -197.00 |
| Mar 31, 2017 | 145.00 |
| Dec 31, 2016 | -10.00 |
| Sep 30, 2016 | 12.00 |
| Jun 30, 2016 | -520.00 |
| Mar 31, 2016 | 190.00 |
| Dec 31, 2015 | 56.00 |
| Sep 30, 2015 | 174.00 |
| Jun 30, 2015 | -392.00 |
| Mar 31, 2015 | 113.00 |
| Dec 31, 2014 | 342.00 |
| Sep 30, 2014 | -169.00 |
| Jun 30, 2014 | -96.00 |